clinixir.com

What It Is

Clinixir is a clinical research services and solutions provider focused on the Thai market. It serves global sponsors with CRO, SMO, research site operations, regulatory affairs, pharmacovigilance, data management, biostatistics, RWE, and HEOR services. Based on the collected information, it is not a typical self-service SaaS product, but rather a professional clinical research services firm centered on project-based delivery.

Core Capabilities

Its services cover the clinical trial lifecycle: from study design, clinical trial applications, IRB coordination, and communication with the Thai FDA, to compliant execution, drug safety monitoring, research site management, and data submission. The regulatory affairs section emphasizes local understanding of Thailand’s processes, CTA, product registration, and classification pathways. Pharmacovigilance covers the identification, assessment, and reporting of ADRs, SAEs, and SUSARs. Biostatistics and data management highlight validated e-clinical systems, data consistency, traceability, and US FDA 21 CFR Part 11. RWE and HEOR are used for real-world effectiveness, cost-effectiveness, patient-reported outcomes, and market access strategy.

Pricing and Delivery

The website does not disclose packages, unit pricing, free trials, or subscription models. It only provides Contact Us and Request RFP Form options, so it should be treated as custom-quoted. Project pricing will likely depend on the study phase, therapeutic area, sample size, number of research sites, regulatory complexity, and scope of data analysis.

Pros and Cons

Its strengths lie in its clearly defined local capabilities in Thailand, covering hospitals, research institutions, regulatory communication, and multiple therapeutic areas, including oncology, metabolic diseases, infectious diseases, rare diseases, medical devices, neurological disorders, and cell/gene therapy. It also addresses common outsourcing needs for sponsors, such as pharmacovigilance, RWE, and HEOR. The drawbacks are the lack of detailed software product information: there is no clear explanation of dashboards, permission systems, APIs, cloud deployment, or third-party integrations. Some pages also contain placeholder text, which affects perceived professionalism and credibility.

Who It’s For and Access from China

Clinixir is suitable for pharmaceutical companies, biotech firms, and medical device companies planning to conduct clinical trials, regulatory submissions, post-marketing studies, or real-world research in Thailand. Chinese companies expanding into Southeast Asian clinical development or registration could evaluate it as a local partner in Thailand. Access from China is not indicated in the available text, and payment methods are not disclosed. If global multi-country coverage is needed, it may be compared with IQVIA, ICON, Parexel, and similar providers. If execution is mainly in mainland China, alternatives such as Tigermed or WuXi AppTec’s clinical services may be more relevant.